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Abstract: Advancements in veterinary medicine have resulted in an increased number of 
 geriatric horses being presented for medical or surgical procedures that require general anesthesia. 
Due to the physiological changes associated with aging and the likelihood of concurrent disease 
conditions, the geriatric equine is at an increased risk during anesthesia. The main physiological 
changes associated with aging, and their impact on anesthesia, are discussed in this review.
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Introduction
Aging is not simply the passage of time, but a physiological, irreversible, and 
progressive process characterized by degenerative changes in the structure and 
functional reserve of organs and tissues,1 and can be defined as the loss of ability 
to adapt to a changing environment.2 Recent advances in veterinary medicine have 
increased the number of geriatric horses being presented for surgical or diagnostic 
procedures that require general anesthesia. Older horses are more likely to suffer 
from gastrointestinal emergencies, dental disease, neoplasia, sinus infections and 
ethmoidal hematomas, esophageal choke, and ocular problems. Data from Colorado 
State University Veterinary Teaching Hospital reported an increase in the percentage 
of horses 15 years or older being admitted for treatment, from 3% in 1973 to 12% 
in 2000.3
The characterizations of age include the chronological age, or how many years 
an animal has been alive; the physiologic age, or how well the animal is functioning 
in comparison to a younger animal; and the demographic age, or how the animal 
compares chronologically with other animals of the same species.3 Clearly, due to the 
presence of concomitant or age-related diseases and environmental factors, there is a 
large variability in physiological status among the geriatric population. Additionally, 
horses may be considered different from humans or small animals as they need to 
remain physically active in their day-to-day existence; therefore, the term functional 
age is used to take into account the horse’s use.4
The age at which a horse is considered aged is unclear, and depends on many 
 factors. As a general guideline based on the chronological age, animals in the last 
25% of the predicted life span for the species and breed are considered aged. Based 
on the average life span of horses and ponies (25 and 30 years, respectively),5 studies 
have considered horses to be geriatric at 20 years of age.6–8
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Physiology of aging
Although increasing age should not be considered a disease 
state per se, aging impedes the body’s ability to cope with 
stress; consequently, aging individuals undergo physiological 
changes that may impact how they respond to anesthesia.9,10 
Generally, in aged humans and animals, the physiological 
reserve and therefore, the ability of the body to maintain 
homeostasis decreases. Almost every body system is affected 
by aging, and many of these changes may affect the pharma-
cokinetics and pharmacodynamics of anesthetic drugs.
Most information on the physiology of aging is based 
on research performed on laboratory animals and humans. 
Although little is known specifically about the effects of 
aging in horses, there is no reason to suspect that horses 
differ from other species in this regard. It seems that no single 
cause is responsible for aging – aging is considered to be a 
multifactorial process,11 and many processes may interact 
simultaneously.12
Theories of aging
A number of theories have been formulated to explain the 
aging process, and can be categorized as evolutionary, 
molecular, cellular, and systemic theories. The evolutionary 
theory states that aging results from a decline in the force of 
natural selection, and longevity is a trait to be selected only if 
it is beneficial for fitness. The molecular theory proposes that 
senescence is caused by changes in gene expression,13 and 
that aging primarily results in damage to genetic material. The 
cellular theory encompasses theories relating to cellular and 
telomere senescence, free-radical damage to lipids, proteins, 
and DNA, and apoptosis subsequent to genetic events or 
genome crisis. The system-based theory of aging ascribes the 
aging process to a decline in the function of essential organs, 
such as in the neuroendocrine and immune systems.
Overall, mitochondrial dysfunction and oxidative stress 
are considered the two main interdependent mechanisms 
responsible for cellular damage and aging. Oxidative stress, 
initiated and propagated by various free radicals, not only 
damages the phospholipid, protein, and DNA molecules 
within the cell, but also modulates cell signaling pathways 
and gene expression patterns.14
Aging and the nervous system
In humans, aging causes a decrease in neural density and 
loss of up to 30% of brain mass by the age of 80 years.1 In 
a study of the brains of horses aged 7–23 years, significant 
microscopic changes, that appeared to be similar to those 
described in elderly people, were observed. These changes 
were indicative of neuronal damage and depletion, and 
arterial wall degeneration.15 Similar nervous system changes 
may be responsible for cognitive dysfunction in elderly 
humans.16,17 Although it is difficult to identify cognitive 
dysfunction in horses, it has been stated that older horses 
respond more slowly to stimuli than do younger horses.5
In elderly humans, cerebral blood flow is reduced by 
10%–20%, in response to a decrease in cerebral metabolic 
rate and decreased cerebral mass. There is a depletion of 
neurotransmitters including catecholamines, serotonin, and 
acetylcholine. Dopamine uptake sites, transporters, and their 
concentration are decreased, as are cortical serotonergic, 
alpha-2, beta adrenergic, and gamma-aminobutyric acid 
(GABA) binding sites, and this may affect memory and motor 
function.1,18 Depletion of nervous system neurotransmitters 
and receptor density has not been evaluated in elderly 
horses; however, the response of the cardiovascular system 
to inotropic agents was reported to be similar to that in 
younger animals.19
The peripheral nervous system goes through age-
associated changes including loss of motor, sensory and 
autonomic f ibers, a decrease in afferent and efferent 
conduction velocities, and progressive decline of signal 
processing rate. A decrease in the efficiency of nerve to 
muscle coupling, and the number of muscle cells innervated 
by an axon, may lead to denervation and muscle atrophy. 
The responsiveness of autonomic end organs is decreased 
in elderly people, despite an increase in plasma epinephrine 
and norepinephrine concentrations.1 However, in a study 
on old beagles, aging did not alter the responsiveness of 
postsynaptic adrenergic and nonadrenergic receptors in 
the skeletal–muscle vasculature of the canine hind-limb, 
in comparison with young animals.20 In the same study, 
the expression of adrenergic and nonadrenergic receptors 
in skeletal muscle arteries was also largely unaffected by 
aging. Thus, animals may differ from humans with regard 
to peripheral nervous system changes.
Human studies have indicated only subtle changes in 
blood–brain barrier function in geriatrics;21 nevertheless, 
studies in humans and animals indicate a decrease in the 
minimum alveolar concentration (MAC) of inhalational 
anesthetics with advancing age.22,23 The decrease in MAC may 
be due to several mechanisms including pharmacodynamic and 
pharmacokinetic alterations.24 For instance, increased blood/
gas solubility of inhalational anesthetics and some biochemical 
alterations such as lower plasma albumin concentration in 
geriatrics may have a role.22,25,26 The anesthetic MAC has 
not been studied in geriatric horses; however, a study in dogs 
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indicated a decrease in the MAC of isoflurane in older dogs, 
and this has been ascribed to changes in N-methyl-D-aspartate 
(NMDA) receptor binding.27
Postoperative cognitive dysfunction (POCD) has been 
described in up to 50% of human patients undergoing 
anesthesia, though most seem to recover with time. Increasing 
age, duration of anesthesia, a second operation, postoperative 
infections, and respiratory complications are risk factors 
for early POCD, but age was found to be the only risk 
factor for late POCD.28,29 Although there is no evidence for 
the occurrence of POCD in geriatric horses, some forms 
of POCD may be expected to occur in geriatric horses 
because anesthetic complications, such as hypoxemia and 
hypotension, are common in this species.
There is no specific protocol for the prevention of 
anesthetic-related insults to the nervous system; however, 
it is plausible that maintaining perioperative homeostasis as 
close to normal as possible may minimize the risk of central 
nervous imbalances resulting from general anesthesia.
Aging and the cardiovascular 
system
Some anomalies, such as valvular heart disease, are more 
prevalent in older horses; whereas, myocardial disease and 
pericarditis are not.30,31 Many of these abnormalities are 
well tolerated clinically, and are not necessarily associated 
with an increased risk of death; but, in a proportion of older 
horses, they may lead to signs of severe cardiac dysfunction. 
It should also be noted that horses with congenital lesions, 
such as ventricular septal defect or patent ductus arteriosus, 
may not develop signs of heart failure until later years.30 In 
a prospective cohort study in horses, it was reported that 
although the prevalence of all causes of death increased with 
age, cardiovascular deaths did not occur in horses younger 
than 15 years of age, and the prevalence of fatality due to 
cardiovascular diseases was 5.1% in the 15–23-year-old 
group and 8.5% in the 24-year-old and older group.32
In humans, aging results in an overall decrease in the 
tonic influence of the parasympathetic nervous system, 
a decline in the responsiveness of beta receptors, and the 
replacement of compliant cardiac and vascular tissue by 
a stiff, fibrotic tissue. These changes blunt chronotropic 
and inotropic responses of the heart, and impair diastolic 
filling. Consequently, the ability of the older patient to 
cope with stress is compromised.33,34 Equine hearts have not 
been studied as thoroughly, but fibrous scarring of the left 
ventricular apex is reported to occur in 60% of hearts from 
horses older than 20 years of age.35 Decreased ventricular 
compliance decreases diastolic filling, increases end-diastolic 
pressure, and makes the heart volume sensitive and volume 
intolerant, and may affect cardiac output.1,36 However, the 
degree to which aging is associated with a decrease in cardiac 
output and stroke volume at rest is controversial. Decreases of 
up to 5% per decade in these parameters have been described 
in humans and, at the age of 80 years, are decreased by 50% 
when compared to a 30-year-old.1,34
Functional cardiac studies in horses have demonstrated 
that maximal heart rate (HR
max
) and aerobic capacity decline 
with age.37,38 The decline in HR
max
 may limit maximal cardiac 
output and, thus, maximal oxygen consumption (VO
2max
) 
and the ability to perform exercise. A decline in VO
2max
 and 
exercise capacity with aging has been reported in horses.37
Valvular heart diseases
Valvular heart disease is the most common form of cardiac 
disease in the horse, with an overall prevalence of 23%, and 
the prevalence seems to be greater in horses 16 years of 
age or older.39 Aortic valve pathology accounts for 82% of 
valvular abnormalities, and the greatest incidence of aortic 
regurgitation is in horses aged 15–20 years.40 Horses with 
aortic insufficiency also appear to be at risk of developing 
supraventricular and ventricular arrhythmias. These 
arrhythmias are rarely recognized on physical examination, 
and require ambulatory and exercising electrocardiographic 
studies to document their presence.30 Other arrhythmias, such 
as ventricular premature beats or ventricular tachycardia, 
may reflect myocarditis.41 S-T segment depression has been 
reported in horses with chordae tendineae rupture, and may 
indicate myocardial ischemia.31 The prevalence of these 
arrhythmias during anesthesia in older horses and their impact 
on cardiovascular physiology has not been investigated.
The incidence of mitral insufficiency is not greater in 
older horses,41 but the intensity of murmurs due to mitral 
insufficiency is reported to be greater in older horses.30 In a 
substantial proportion of horses presenting with severe mitral 
insufficiency, there is concurrent myocardial fibrosis and, in 
some of these animals, myocardial lesions are considered 
to be the primary disease leading to mitral insufficiency.41 
Another study indicated that age was a significant risk factor 
for mortality associated with aortic and mitral insufficiency.32 
Increases in left atrial pressure secondary to mitral 
regurgitation may result in an increase in left atrial diameter, 
and these horses have an increased risk of developing atrial 
fibrillation.31 Horses with pulmonary hypertension, as a 
sequela of mitral regurgitation, are at risk for sudden death 
secondary to rupture of the pulmonary artery.41
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Aortocardiac fistula
Aortocardiac fistula, although first described as a disease 
of older stallions, is not unique to older horses.30,42,43 The 
etiology of this condition is unclear, but it occurs as a result 
of rupture of the right aortic sinus. The aorta ruptures directly 
into the right atrium or ventricle or forms a fistulous tract 
through the aortic ring or ventricular septum to the left or 
right ventricle or right atrium. Stallions older than 5 years 
of age are most commonly affected.43
Age-associated vascular changes
In aged humans, the vascular system is affected by a decrease 
in the tonic influence of the parasympathetic nervous system, 
and changes in the vascular wall.33,34 Vascular changes 
result in arterial and venous rigidity, an increase in systemic 
vascular resistance, and a decrease in venous compliance. 
Mineralization of the intimal layer of blood vessels is a 
common finding in the cerebral arteries, capillaries, and veins 
of old horses, although its clinical importance is not clear.44 
The loss of elasticity in large arteries causes a progressive 
increase in systemic blood pressure and widening of pulse 
pressure. Increased sympathetic nervous system activity may 
also contribute to the increase in systemic vascular resistance. 
Age-associated vascular changes in horses are not well 
documented; however, in one study, there was no difference 
in arterial blood pressures in horses less than 15 years and 
those over 20 years.5
A decrease in venous compliance decreases the ability 
to compensate for changes in intravascular volume, and 
exaggerates hypotension resulting from blood loss, or 
from peripheral pooling of blood observed during general 
or regional anesthesia.45,46 Other factors predisposing 
to hypotension may include diminished sensitivity of 
baroreceptor and beta receptors’ response, and decreased 
response of the renin/aldosterone/angiotensin system in 
advanced age.45,47 Hypotension is one of the common 
complications during equine general anesthesia and these 
vascular changes may further predispose the geriatric horse 
to hypotension. However, in anesthetized horses, age did 
not have an effect on the response to dobutamine therapy, 
indicating that there was no decrease in the responsiveness 
of beta receptors.19 Nevertheless, preliminary data indicates 
that geriatric horses are more prone to the cardiovascular 
depressant effects of inhalational anesthetics.5
Aging and the pulmonary system
Several anatomical and physiological changes in the 
pulmonary system occur with aging. The main changes 
are increased compliance and decreased elastic recoil 
of the lungs, and decreased respiratory muscle function 
and chest wall compliance. Decreased chest compliance 
and lung recoil increases residual and closing volumes, and 
dead space ventilation. In elderly people, the dynamic lung 
compliance becomes frequency dependent. As breathing rate 
increases, lung expansion becomes less effective and ven-
tilation to perfusion (V/Q) mismatch increases.1 A similar 
pathophysiology may be responsible, at least in part, for 
development of V/Q mismatch in geriatric horses. These 
changes, along with a decrease in alveolar surface area and 
an increase in shunting, result in decreased gas exchange 
efficiency, decreased arterial oxygen partial pressures 
(PaO
2
), and greater alveolar-arterial oxygen difference (A-a 
difference).4,5 Decreased PaO
2
 and greater (A-a) O
2
 differ-
ence were reported in awake horses older than 20 years of 
age when compared to a group of younger horses.8 In that 
study, PaCO
2
 values in older horses were less, and the pH 
was greater, compared to the younger animals, indicating a 
compensatory hyperventilation.
In the elderly, loss of respiratory muscle fibers and a 
decrease in central and peripherally mediated ventilatory 




 or airway stimula-
tion have been reported,48 and are likely to occur to some 
degree in older horses.4,5 In recumbent horses under 
inhalational anesthesia, functional residual capacity and 
residual volume are reduced, and PaO
2
 values are often 
decreased, despite the use of maximal fraction of inspired 
oxygen.49,50
Recurrent airway obstruction
Recurrent airway obstruction (RAO) (heaves) is the most 
common respiratory disorder in older horses.51,52 This 
recurrent inflammatory condition can cause permanent 
pulmonary remodeling and fibrosis, if not treated initially. 
Airway smooth muscle and pulmonary epithelial hypertrophy 
may result in a net loss of intra-alveolar septae and pulmonary 
capillaries, with an increased number of intra-alveolar 
pores and deposition of collagen. Exercise intolerance, 
respiratory distress, chronic coughing, mucopurulent nasal 
discharge, abnormal pulmonary sounds, and an enlarged 
f ield of percussion are usually noted during physical 
examination. In these animals, pulmonary arterial pressure 
is increased, gas exchange is compromised, and end-expired 
lung volume is increased.53,54 Due to an overall decrease in 
respiratory functional reserve, greater (A-a) O
2
 difference 
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is of particular concern. The PaO
2
 is usually decreased, 
indicating impairment of pulmonary gas exchange. Therefore, 
providing mechanical ventilation during general anesthesia 
may correct blood gas abnormalities. As these horses usually 
suffer from increased pulmonary resistance, bronchodilators 
(beta-2 adrenergic agonists and parasympathomimetics) 
are efficacious in relieving smooth muscle contraction in 
the lower airways and the associated respiratory distress.55 
The administration of bronchodilators, such as aerosolized 
albuterol,56 during anesthesia may improve oxygenation 
and ventilatory parameters. Recently, however, it has been 
shown that the S-enantiomer of salbutamol can elicit an 
increase in the contraction of equine airway smooth muscle 
on isolated equine bronchi; thus, only the R-enantiomer is 
recommended for use.57
infectious pulmonary diseases
Although bacterial pneumonia is independent of age, geriatric 
horses suffering from subclinical or undiagnosed pituitary 
pars intermedia dysfunction (PPID) and increased serum 
cortisol, are more prone to secondary bacterial pneumonia 
due to immunosuppression. Bacterial pulmonary disease 
may also occur secondary to upper airway viral pathogens 
and RAO.
Aging and the musculoskeletal 
system
Musculoskeletal diseases are among the most commonly 
reported clinical problems in aged horses.58 Periarticular 
degenerative diseases of the axial skeleton in aged horses 
may be sufficiently advanced to compromise spinal cord 
function.35 Osteoarthritic degenerative changes affect 
the overall function of the musculoskeletal system, and 
may  compromise the quality of recovery from general 
anesthesia.
The loss of skeletal muscle and lean body mass that 
occurs with aging is referred to as sarcopenia.59 Sarcopenia 
encompasses the effects of changes in central and peripheral 
nervous system innervation, hormonal status, inflammation, 
altered caloric and protein intake, and cumulatively results in 
loss of muscle fiber and fiber atrophy.2,60 Sarcopenia is only 
now being recognized in veterinary patients.61 In humans, 
age-associated changes in muscle strength are directly 
 correlated with the loss of skeletal muscle mass. A decrease 
of approximately 40% in total muscle cross-sectional area 
occurs in humans between the ages of 20 and 60 years.62,63 
Significant age-related changes responsible for loss of muscle 
mass and strength may include changes in motor units, 
muscle fibers, and muscle protein.64–67 These changes affect 
spatial organization and physiological properties of fast- and 
slow-twitch single motor units, regulation of contractile speed 
and force generation capacity of muscle fibers, and functional 
properties of myosin.68 There is also a disorganization of 
coordinated expression of contractile, sarcoplasmic  reticular 
and mitochondrial protein isoforms in aging skeletal 
 muscle.64 The net effect of aging on  neuromuscular  function 
is a reduction in contractile strength, proprioception, and 
coordination.
It is clear that many older horses lose muscle mass; 
 however, many others remain active and appear well 
 muscled. Decreased muscle mass in a horse will have a 
significant impact on the anesthetic outcome, as the horse’s 
ability to stand during recovery may be compromised. 
 Sarcopenia may also contribute to increased heat loss under 
general anesthesia. Lean animals lose core temperature faster 
than animals with sufficient muscle mass, and this is well 
demonstrated in elderly humans.69
Aging and the endocrine system
Cushing’s disease (pituitary pars 
intermedia dysfunction – PPiD)
Cushing’s disease, one of the most common endocrine 
abnormalities of older horses, is the consequence of gluco-
corticoids acting in excess of physiological requirements.70 
The prevalence of Cushing’s disease has increased during 
the past several years and has an incidence of 0.5%. It is 
primarily observed in horses 18–21 years old.71 Horses with 
Cushing’s may be more sensitive to sedatives and anesthetics 
as a consequence of muscle wasting and fat redistribution. 
Also, corticosteroid-induced changes such as hepatopathy, 
immunosuppression, and osteoporosis may affect drug 
metabolism, pulmonary function (due to pneumonia), and 
the quality of recovery.71,72
Cardiopulmonary changes such as tachypnea, tachycardia, 
and hypertension are not uncommon in horses with 
Cushing’s disease.72 The vascular smooth muscle may 
be more responsive to catecholamines,73 and some of the 
cardiovascular instability present in geriatric animals may 
be counteracted in animals with Cushing’s disease due 
to an overall increase in sensitivity of the cardiovascular 
system to adrenergic agents. However, vasoconstriction 
and hypovolemia may result in reduced tissue perfusion, 
and volume-loading of these animals prior to anesthesia is 
recommended.5 Secondary diabetes mellitus or insipidus, 
blood glucose, fluid, and electrolyte abnormalities may 
also be present in these horses, and hyperhidrosis may 
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contribute to the hypovolemia and hypokalemia.70,72 Due to 
the catabolic effect of corticosteroids, these horses may be 
sarcopenic, thus, supporting ventilation and recovery may 
be necessary.5 Dopamine agonists or serotonin antagonists 
are used to treat Cushing’s disease, and adverse effects such 
as hypotension, agitation, cardiac arrhythmias, and sedation 
have been reported with treatment.74–76
Hypothyroidism
Hypothyroidism is associated with aging in horses.4 Primary 
hypothyroidism, as an autoimmune disease, has been reported 
in specific instances in horses.70 Secondary hypothyroidism may 
be due to hyperadrenocorticism or surgical thyroidectomy.70,72 
Physiological changes after surgical thyroidectomy in horses 
may include decreases in resting heart rate, cardiac output, 
respiratory rate, and body temperature, and slight increases in 
plasma and blood volume may be observed. Hypothyroidism 
may contribute to bradycardia and hypotension during anes-
thesia, and the beta adrenergic responses may also change, as 
the heart rate increase in response to isoproterenol was less in 
horses after thyroidectomy.77
Identification and treatment of the underlying cause (if 
any) of secondary hypothyroidism should be performed prior 
to anesthesia. Although thyroid hormone supplementation 
in horses is of unknown benefit, it may be beneficial in 
secondary hypothyroidism.78
In summary, full evaluation of endocrine abnormalities 
and correcting the imbalances should be performed prior to 
anesthesia, particularly for elective procedures.
Pharmacological considerations  
in geriatrics
The pharmacokinetics of anesthetic drugs in geriatric animals 
may be altered by changes in physiological parameters such 
as a decreased metabolic rate and cardiac output, increased 
ratio of fat to muscle tissue, decreased cerebral blood flow, 
a decrease in the concentration of plasma protein, and volume 
of distribution of particular drugs.79,80 In older people, smaller 
initial volumes of distribution and slower intercompartmental 
clearance rates, redistribution, metabolism, and excretion for 
propofol and thiopenthal are reported, and as much as a 50% 
decrease in the dose may be indicated.79,81,82 It is suggested 
that geriatric horses may experience more intense and longer 
lasting analgesia with butorphanol and morphine for standing 
sedation.5 The decreased lean body mass in geriatric animals 
will cause a smaller amount of the drug to be directed into the 
muscles;83 thus, a greater fraction of the drug will reach the 
brain. There is a paucity of information on the effect of aging 
on these parameters in horses; but total protein and albumin 
concentrations in several groups of horses older than 20 years 
of age were similar to those of young horses.6,7
The pharmacodynamics of anesthetic drugs may be 
altered in geriatric animals due to changes in receptor 
sensitivity. Alterations in receptor activity of opioids 
and benzodiazepines have been documented in geriatric 
people.79,84 For instance, binding of the channel protein 
associated with NMDA receptors increases with age,85 and 
occupied benzodiazepine receptors create a relatively greater 
depression of neuronal activity.80 Age-related changes in 
brain NMDA receptor binding and a decrease in the MAC of 
isoflurane have been demonstrated in geriatric dogs.27
Clearance of most anesthetics is prolonged in the 
elderly.79 Recovery from anesthesia may be prolonged due 
to decreases in drug clearance and tissue perfusion, and a 
greater proportion of adipose tissue, which acts as a ‘sink’ 
for lipid soluble drugs.
A decrease in liver blood flow during anesthesia 
may also have a significant effect on the clearance of 
drugs with a high extraction ratio (eg, ketamine and 
morphine), because hepatic clearance is proportional to 
liver blood flow.79,86,87 In contrast, the clearance rate for 
anesthetic drugs with a low extraction ratio (eg, diazepam 
and thiopental) is limited by the metabolizing capacity 
of the liver.86 Hepatic clearance of benzodiazepines is 
slower in aged people;88 thus, repeated or large doses of 
benzodiazepines may prolong recovery.
There is an age-associated increase in sensitivity to 
opioids and a linear decrease in epidural dose requirements 
in people.89 Factors such as the anatomical changes 
influencing the size and patency of the intervertebral 
foramina, alterations in local blood flow, and changes 
in nerve fibers and their integuments inside and outside 
the spinal cord, are potential reasons for the difference in 
pharmacodynamics of epidurally administered opioids. This 
may also be the case in geriatric horses, as it was reported 
that a 25-year-old horse with an infected pelvic limb tendon 
sheath, required a smaller than expected dose of epidural 
morphine to control pain.5
Renal clearance of drugs may also be affected by the 
aging process, and although serum creatinine concentrations 
may be within the normal range in geriatric people, creatinine 
clearance may be decreased,79 indicating decreased renal 
reserve. In a study of healthy horses older than 20 years, no 
abnormality in serum urea nitrogen, creatinine, albumin, liver 
enzyme activities, and electrolytes was found;7 creatinine 
clearance was however, not measured.
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Anesthetic considerations  
in geriatric horses
Anesthetic morbidity and mortality  
in geriatrics
In humans, anesthetic associated morbidity and mortality 
increase with aging,1 and the same is true for horses. In a 
study of more than 41,000 horses, those aged 14 years or 
older were at greater risk of mortality (odds ratio of 1.42).90 
The two main reasons for increased mortality in older horses 
were an increased risk of long-bone fracture during recovery, 
and an increased likelihood of co-existing diseases affecting 
the outcome.90 In another study on more than 17,000 horses 
undergoing general anesthesia, there were 42 (0.24%) 
perianesthetic fatalities.91 Although the relationship between 
age and mortality was not evaluated as a covariant in that 
study, the six Thoroughbred mares that fractured a long-bone 
during recovery were older (9–18 years). Older mares may 
be at an increased risk of long-bone fracture, as bone density 
studies have reported decreased metacarpal breaking strength 
in some older mares up to 40 weeks post-parturition.92
Preanesthetic evaluation of the geriatric 
horse
After obtaining a complete history of use, exercise tolerance, 
and ability to rise from recumbency, a thorough physical 
examination should be performed. A physical examination 
during rest and exercise has been suggested, because exercise 
may unmask diseases such as RAO and cardiac diseases that 
are not apparent at rest. In clinically healthy geriatric horses, 
the authors perform only basic laboratory tests (hematocrit and 
total protein determination); however, in sick horses a complete 
and differential blood count and biochemical analysis may be 
indicated. If significant cardiac murmurs or arrhythmias are 
present, a complete cardiac evaluation is recommended.
Standing sedation
Many procedures, such as surgery of sinuses, dental surgery, 
and laparoscopic surgery can be performed with the horse 
standing and sedated, in association with local or regional 
anesthesia. Standing surgery avoids the problems associ-
ated with general anesthesia and recovery, and should be 
performed, whenever possible, in geriatric horses.
Drugs used for sedation
Acepromazine
Does not give reliable sedation, and may cause hypotension, 
especially if large doses are used. Acepromazine has been 
mainly replaced by alpha-2 agonists, but small doses 
(0.02 mg/kg, IV) can be combined with an alpha-2 agonist 
for more profound sedation and analgesia.4
Opioids
Opioids such as butorphanol, morphine, and meperidine, 
are not used alone for sedation because they may cause 
dysphoria or excitement, especially if given as a bolus IV 
to an unsedated horse; however, they have synergistic or 
additive analgesic and sedative effects with other drugs such 
as alpha-2 agonists. Therefore, opioids are usually combined 
with alpha-2 agonists, as described below. Additionally, 
histamine release and hypotension may result, especially if 
meperidine is administered IV.
Alpha-2 agonists
This group of drugs provides dose-dependent sedation and 
analgesia, thus, they can be administered to effect. They also 
have the advantage of being reversible. In geriatric horses, the 
authors initially administer a small dose of an alpha-2 agonist 
(eg, xylazine 0.25–0.5 mg/kg, IV). Xylazine is the shortest 
acting alpha-2 agonist and, thus, may be most suitable for use 
in geriatric horses. Short-term sedation is usually achieved 
by administering an alpha-2 agonist as a bolus; however, 
a constant rate infusion (CRI) will give more reliable sedation 
for prolonged procedures. To provide more reliable sedation 
and analgesia, an alpha-2 agonist can be combined with 
an opioid. The alpha-2 agonist bolus dose depends on the 
degree of sedation and analgesia required, and IV doses in 
the following ranges are recommended by the authors:
•	 Xylazine (0.25–1 mg/kg)
•	 Detomidine (0.0025–0.01 mg/kg)
•	 Romifidine (0.025–0.1 mg/kg)
•	 Dexmedetomidine (0.0015–0.0025 mg/kg).
If combining alpha-2 agonists with an opioid, it is 
important that the horse is sedated before the opioid is 
administered, to prevent opioid-induced excitement. In 
addition, it is important to administer the drugs slowly, and in 
increments, to achieve the desired effect and avoid excessive 
sedation and ataxia.
The authors suggest the following IV drug doses when 
combining alpha-2 agonists and opioids:
•	 Xylazine (0.25–1.0 mg/kg) plus butorphanol (0.01–
0.02 mg/kg) or morphine (0.1 mg/kg)
•	 Detomidine (0.0025–0.005 mg/kg) plus butorphanol 
(0.01–0.02 mg/kg) or morphine (0.1 mg/kg)
•	 Romifidine (0.03–0.06 mg/kg) plus butorphanol (0.01–
0.02 mg/kg) or morphine (0.1 mg/kg)
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•	 Dexmedetomidine (0.001–0.002 mg/kg) plus butorphanol 
(0.01–0.02 mg/kg) or morphine (0.1 mg/kg).
Constant rate infusions
Constant rate infusions (CRI) are used to deliver sedative-
analgesic drugs when prolonged sedation-analgesia is 
required, as when surgery is performed on a standing horse. 
A CRI provides a more steady state of sedation than intermittent 
bolus administration of a drug(s). A CRI can be delivered by 
adding the drug(s) to a bag of balanced electrolyte solution 
and determining the drip rate; however, to be more accurate, 
the drugs can be delivered using a syringe pump or fluid 
pump. A loading dose (Ld) is delivered initially, and the 
CRI is then started. Alpha-2 doses in the following ranges 
are recommended:
•	 Xylazine: Ld = 0.25–1 mg/kg IV and a CRI = 
0.5–1.0 mg/kg/hour
•	 Detomidine: Ld = 0.0025–0.01 mg/kg IV and a 
CRI = 0.01–0.02 mg/kg/hour
•	 Dexmedetomidine: Ld = 0. 0015–0.0025 mg/kg IV and 
a CRI of 0.0015–0.0025 mg/kg/hour
•	 Romif idine:  Ld =  0.03–0.1 mg/kg IV and a 
CRI = 0.01–0.02 mg/kg/hour.
If an opioid is added, the dose of the alpha-2 agonist is 
decreased to avoid excessive sedation and ataxia. Doses in 
the following range are used by the authors:
•	 Detomidine: Ld = 0.0025–0.005 mg/kg IV and a 
CRI = 0.01 mg/kg/hour, plus
•	 Butorphanol: Ld = 0.01–0.02 mg/kg, IV and a 
CRI = 0.012 mg/kg/hour or morphine: Ld = 0.10 mg/kg, 
IV over 10 minutes, and a CRI = 0.15 mg/kg/hour.
Detomidine is the most frequently used alpha-2 
agonist, but others may be used in place of detomidine. 
For most procedures lasting less than 2 hours, the authors 
just use a loading dose of morphine without a CRI. It is 
especially important in geriatric horses that the loading 
dose of morphine be administered slowly to avoid excessive 
sedation.
Reversal of alpha-2 agonists
Yohimbine and atipamezole are the most commonly used 
alpha-2 antagonists. Because alpha-2 antagonists can induce 
serious adverse effects, including hypotension, airway 
edema, and excitation, they must be administered slowly. 
Yohimbine is a less specific antagonist, and can be used in 
doses of 0.025–0.05 mg/kg, given slowly IV. The authors 
usually administer yohimbine over 10 minutes. The mean 
effective half-life of yohimbine is about 1 hour, and this 
prevents relapse of sedation in most horses.93 The affinity 
of atipamezole for alpha-2 receptors is 100 times greater 
than that of other antagonists, and the authors use a dose of 
0.02–0.04 mg/kg, IV over 10 minutes.
induction of anesthesia
There are a limited number of drug combinations for 
induction of anesthesia. Although it may be best to administer 
induction drugs to effect, the size of the horse makes this 
impractical. In any case, geriatric horses tolerate induction 
of anesthesia quite well if cardiovascularly stable.
induction regimens
Ketamine and a benzodiazepine
This is the most common regimen for induction of anesthesia, 
after sedation with an alpha-2 agonist (eg, xylazine 0.5–
1.0 mg/kg). For this purpose, ketamine (1.5–2.2 mg/kg) 
and diazepam or midazolam (0.02–0.1 mg/kg) can be 
combined in the same syringe and administered as a bolus.4 
The benzodiazepine improves muscle relaxation and 
sedation.
Guaiphenesin and ketamine
Guaiphenesin, a centrally acting muscle relaxant, is generally 
administered as a 5% solution. It is used to facilitate induction 
of anesthesia in the sedated horse, and many clinicians 
include guaiphenesin in the regimen in order to decrease the 
dose of alpha-2 agonist. Guaiphenesin can be administered 
by one of two methods: after the horse becomes sedated, 
guaiphenesin (30–50 mg/kg, IV) is administered rapidly 
until the horse becomes ataxic, at which point, ketamine 
is administered as a bolus. Alternatively, ketamine can 
be mixed with the guaiphenesin, and the mixture given to 
effect until recumbency. Although this allows the mixture 
to be given somewhat to effect, it is important to administer 
approximately half of the mixture rapidly to avoid excessive 
ataxia.4
Maintenance of anesthesia
General anesthesia can be maintained with inhalational, total 
intravenous anesthesia or partial intravenous anesthesia. 
Inhalational anesthesia is the most common method of 
maintaining anesthesia. The MAC of inhalational anesthetics 
is likely to be 10%–20% less in geriatric horses. Inhalational 
anesthetics generally cause hypotension,94,95 and geriatric 
patients may be more prone to hypotension.5
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Total intravenous anesthesia (TiVA)
Drug kinetics may be altered in geriatric horses, and drug 
accumulation may occur during long infusions; thus, 
decreasing the infusion rate over time may manage this 
problem. Nevertheless, the authors have used TIVA, without 
complication, in older horses. These horses may remain 
recumbent for longer after TIVA, but the recoveries are 
generally more controlled than with inhalational anesthetics. 
Another advantage of TIVA is the decreased incidence of 
intraoperative hypotension.
Anesthesia can be induced as described above. The 
most commonly used drug combination is ketamine and an 
alpha-2 agonist with guaiphenesin. The authors suggest that 
ketamine (1–1.5 g) and xylazine (500 mg) be added to 1 L 
of a 5% solution of guaiphenesin and infused at the rate of 
2–3 mL/kg/hour. This mixture is also known as triple drip. 
Because guaiphenesin is cleared slowly it may contribute 
to weakness in recovery; thus, the authors recommend that 
it only be administered for the first hour. Beyond this time, 
anesthesia is maintained with ketamine and xylazine diluted 
in a balanced electrolyte solution.
Partial intravenous anesthesia (PiVA)
This is the combination of inhalational and intravenous 
anesthetics, and has been used successfully by the authors 
in geriatric horses. In the authors’ hospital, ketamine 
(2–2.5 mg/kg/hour), xylazine (0.25 mg/kg/hour), and lidocaine 
(3–6 mg/kg/hour) are used in conjunction with isoflurane at an 
end-tidal concentration of 0.5%. A loading dose of lidocaine 
(3 mg/kg over 15 minutes) is followed by an infusion of 
6 mg/kg/hour for the first hour, and 3 mg/kg/hour in subsequent 
hours. Intraoperative analgesia and a decreased incidence of 
hypotension are the main advantages of PIVA.
Respiratory support during general 
anesthesia in geriatric horses
In horses with recurrent airway obstruction, the medications 
used to modify airway resistance and responsiveness, such 
as beta-2 agonists, must not be withheld  preoperatively.5 
 Controlled mechanical ventilation is recommended, because 
the adaptive active abdominal phase of expiration, in 
response to greater airway resistance, is lost under general 
anesthesia. These animals are prone to alveolar hyperinflation 
and increased intrathoracic pressure, thus, during mechanical 
ventilation, the expiratory time should be sufficiently long 
to allow for a full expiration.5 Moderate permissive hyper-
capnea, and use of a pressure-cycled ventilator, in contrast 
to volume-cycled ventilator, may help prevent progressive 
hyperinflation of the lung.5 Supporting ventilation and 
oxygenation during recovery is also important, and can be 
achieved by using an oxygen demand valve.
Anesthetic concerns in geriatric horses 
with musculoskeletal disorders
Horses with significant musculoskeletal abnormalities 
(eg, osteoarthritis and sarcopenia) are at increased risk of 
anesthetic complications. The decrease in metabolic rate 
and muscle mass predispose to hypothermia; thus, active 
heating may be indicated. Padding and proper positioning 
are very important in optimizing the outcome. Assistance 
during recovery may be necessary due to muscle weakness 
and osteoarthritis.5 The authors routinely use head and tail 
ropes to assist recovery in geriatric horses.
Anesthetic monitoring and pain control 
in geriatric animals
Monitoring during anesthesia is important because geriatric 
horses may have limited physiological reserve. The minimum 
anesthetic monitoring includes assessment of anesthetic 
depth and indicators of cardiopulmonary function (capillary 
refill time, pulse quality, and rhythm). Arterial blood 
pressure measurement, preferably a direct measurement, is 
recommended. A minimum mean blood pressure of 70 mmHg 
should be maintained, using an inotrope (eg, dobutamine), 
if necessary. The ECG should be monitored closely due to 
the increased incidence of arrhythmias in older horses, and 
arterial blood gases analysis monitoring is advisable due to 
the increased incident of hypoxemia in this age group.
Control of pain in geriatric animals, especially those 
that may suffer from underlying painful conditions such 
as musculoskeletal diseases or those that undergo surgical 
procedures, has a significant role in assuring a more 
favorable anesthetic outcome. Preoperative administration of 
nonsteroidal anti-inflammatory drugs, if not contraindicated, 
intraoperative administration of analgesics as components 
of TIVA or PIVA, and the use of local–regional blocks, are 
among the techniques that can be recommended to control 
perianesthetic pain and minimize the stress response.
In summary, age-associated physiological changes in 
geriatric horses make them prone to anesthetic complications. 
However, by administering a balanced anesthesia regimen, 
closely monitoring of body systems during anesthesia, and 
assisting with recovery, as well as controlling pain, the 
anesthetic outcome can be optimized.
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